The Germany-based company inked an exclusive licensing partnership earlier this year with AFT Pharmaceuticals (ASX:AFP) to commercialize Novaliq’s water-free topical eye drops in Australia.
Get the full story at our sister site, Drug Delivery Business News.
The post Novaliq’s NovaTears dry eye disease therapy launches in New Zealand appeared first on MassDevice.
from MassDevice http://ift.tt/2yYKvQ4
Cap comentari:
Publica un comentari a l'entrada